October 27, 2023 10:21 AM EDT
News Briefing

In­tas to pay €42M up­front in Hen­lius deal; Kymera gets $40M mile­stone; Plu­vic­to no longer in short sup­ply

Jaimy Lee

Deputy Editor

Anna Brown

News Reporter

Plus, news from Vi­core, El­e­vate Bio, Monte Rosa Ther­a­peu­tics and An­gi­tia:

In­tas, Hen­lius ink an­oth­er deal: In­tas said Fri­day it plans …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Trump names Johns Hop­kins re­searcher Mar­ty Makary to lead the FDA; al­so names CDC, Sur­geon Gen­er­al picks

FDA ap­proves Bridge­Bio's heart dis­ease drug, set­ting up com­pe­ti­tion with Pfiz­er, Al­ny­lam

Drug or bi­o­log­ic? An Eli Lil­ly law­suit could im­pact weight loss drug com­pounders

Sur­round­ed by AI bio gi­ants, tiny start­up Nabla Bio makes de no­vo an­ti­bod­ies look more like drugs 

Pa­tient dies in Neu­ro­gene's Rett syn­drome study

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times